Janus Henderson Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,123
Closed -$21.9K 2698
2022
Q4
$21.9K Sell
10,123
-10,121
-50% -$83.3K ﹤0.01% 2451
2022
Q3
$242K Buy
20,244
+10,079
+99% +$125K ﹤0.01% 2307
2022
Q2
$85K Buy
10,165
+74
+0.7% +$573 ﹤0.01% 2498
2022
Q1
$87K Buy
10,091
+4
+0% +$39 ﹤0.01% 2579
2021
Q4
$114K Buy
+10,087
New +$120K ﹤0.01% 2492

Other funds holding GOSS

Janus Henderson Group's GOSS Position: Q1 2023 in Review

Janus Henderson Group sold out of Gossamer Bio (GOSS) in Q1 2023, closing a stake of 10,123 shares — an estimated $21.9K sold.

Janus Henderson Group first reported a position in GOSS in Q4 2021 and held it in 5 quarters. The position peaked at $242K in Q3 2022. 111 funds tracked by Wall St. Rank hold GOSS as of Q1 2023.

  • Janus Henderson Group reported no remaining Gossamer Bio position as of Q1 2023 after selling out during the quarter.
  • Janus Henderson Group sold 10,123 Gossamer Bio shares in Q1 2023, an estimated $21.9K.
  • Janus Henderson Group first reported a position in Gossamer Bio in Q4 2021 and held it in 5 quarters.
  • Janus Henderson Group's Gossamer Bio position peaked at $242K in Q3 2022.
  • 111 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2023.

Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.